652 related articles for article (PubMed ID: 18783541)
1. Ezetimibe prevents cholesterol gallstone formation in mice.
Zúñiga S; Molina H; Azocar L; Amigo L; Nervi F; Pimentel F; Jarufe N; Arrese M; Lammert F; Miquel JF
Liver Int; 2008 Aug; 28(7):935-47. PubMed ID: 18783541
[TBL] [Abstract][Full Text] [Related]
2. Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones.
Wang HH; Portincasa P; Mendez-Sanchez N; Uribe M; Wang DQ
Gastroenterology; 2008 Jun; 134(7):2101-10. PubMed ID: 18442485
[TBL] [Abstract][Full Text] [Related]
3. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption.
Altmann SW; Davis HR; Zhu LJ; Yao X; Hoos LM; Tetzloff G; Iyer SP; Maguire M; Golovko A; Zeng M; Wang L; Murgolo N; Graziano MP
Science; 2004 Feb; 303(5661):1201-4. PubMed ID: 14976318
[TBL] [Abstract][Full Text] [Related]
4. Differences between hepatic and biliary lipid metabolism and secretion in genetically gallstone-susceptible and gallstone-resistant mice.
Xu G; Zhao L; Fuchs M
Chin Med J (Engl); 2002 Sep; 115(9):1292-5. PubMed ID: 12411097
[TBL] [Abstract][Full Text] [Related]
5. Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice.
Zheng S; Hoos L; Cook J; Tetzloff G; Davis H; van Heek M; Hwa JJ
Eur J Pharmacol; 2008 Apr; 584(1):118-24. PubMed ID: 18329014
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of intestinal cholesterol absorption by ezetimibe is a novel therapeutic target for fatty liver.
Yamagishi S; Nakamura K; Matsui T; Sato T; Takeuchi M
Med Hypotheses; 2006; 66(4):844-6. PubMed ID: 16188393
[TBL] [Abstract][Full Text] [Related]
7. Ezetimibe prevents the formation of oestrogen-induced cholesterol gallstones in mice.
de Bari O; Wang HH; Portincasa P; Paik CN; Liu M; Wang DQ
Eur J Clin Invest; 2014 Dec; 44(12):1159-68. PubMed ID: 25303682
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of hepatic microsomal triglyceride transfer protein protects mice from diet-induced gallstones.
Amigo L; Castro J; Miquel JF; Zanlungo S; Young S; Nervi F
Gastroenterology; 2006 Dec; 131(6):1870-8. PubMed ID: 17064699
[TBL] [Abstract][Full Text] [Related]
9. Hepatic Niemann-Pick C1-like 1.
Pramfalk C; Jiang ZY; Parini P
Curr Opin Lipidol; 2011 Jun; 22(3):225-30. PubMed ID: 21494140
[TBL] [Abstract][Full Text] [Related]
10. Biliary lipid secretion, bile acid metabolism, and gallstone formation are not impaired in hepatic lipase-deficient mice.
Amigo L; Mardones P; Ferrada C; Zanlungo S; Nervi F; Miquel JF; Rigotti A
Hepatology; 2003 Sep; 38(3):726-34. PubMed ID: 12939599
[TBL] [Abstract][Full Text] [Related]
11. The cholesterol absorption inhibitor ezetimibe acts by blocking the sterol-induced internalization of NPC1L1.
Ge L; Wang J; Qi W; Miao HH; Cao J; Qu YX; Li BL; Song BL
Cell Metab; 2008 Jun; 7(6):508-19. PubMed ID: 18522832
[TBL] [Abstract][Full Text] [Related]
12. Activation of liver X receptor sensitizes mice to gallbladder cholesterol crystallization.
Uppal H; Zhai Y; Gangopadhyay A; Khadem S; Ren S; Moser JA; Xie W
Hepatology; 2008 Apr; 47(4):1331-42. PubMed ID: 18318438
[TBL] [Abstract][Full Text] [Related]
13. Combination of curcumin and piperine prevents formation of gallstones in C57BL6 mice fed on lithogenic diet: whether NPC1L1/SREBP2 participates in this process?
Li Y; Li M; Wu S; Tian Y
Lipids Health Dis; 2015 Sep; 14():100. PubMed ID: 26335572
[TBL] [Abstract][Full Text] [Related]
14. Deficiency of Niemann-Pick C1 Like 1 prevents atherosclerosis in ApoE-/- mice.
Davis HR; Hoos LM; Tetzloff G; Maguire M; Zhu LJ; Graziano MP; Altmann SW
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):841-9. PubMed ID: 17218600
[TBL] [Abstract][Full Text] [Related]
15. Effects of sphingolipid synthesis inhibition on cholesterol gallstone formation in C57BL/6J mice.
Lee BJ; Kim JS; Kim BK; Jung SJ; Joo MK; Hong SG; Kim JS; Kim JH; Yeon JE; Park JJ; Byun KS; Bak YT; Yoo HS; Oh S
J Gastroenterol Hepatol; 2010 Jun; 25(6):1105-10. PubMed ID: 20594226
[TBL] [Abstract][Full Text] [Related]
16. Class B scavenger receptor-mediated intestinal absorption of dietary beta-carotene and cholesterol.
van Bennekum A; Werder M; Thuahnai ST; Han CH; Duong P; Williams DL; Wettstein P; Schulthess G; Phillips MC; Hauser H
Biochemistry; 2005 Mar; 44(11):4517-25. PubMed ID: 15766282
[TBL] [Abstract][Full Text] [Related]
17. Disodium ascorbyl phytostanol phosphate (FM-VP4), a modified phytostanol, is a highly active hypocholesterolaemic agent that affects the enterohepatic circulation of both cholesterol and bile acids in mice.
Méndez-González J; Süren-Castillo S; Calpe-Berdiel L; Rotllan N; Vázquez-Carrera M; Escolà-Gil JC; Blanco-Vaca F
Br J Nutr; 2010 Jan; 103(2):153-60. PubMed ID: 19822032
[TBL] [Abstract][Full Text] [Related]
18. Pioglitazone prevents cholesterol gallstone formation through the regulation of cholesterol homeostasis in guinea pigs with a lithogenic diet.
Han T; Lv Y; Wang S; Hu T; Hong H; Fu Z
Lipids Health Dis; 2019 Dec; 18(1):218. PubMed ID: 31829191
[TBL] [Abstract][Full Text] [Related]
19. Fenugreek seeds reduce atherogenic diet-induced cholesterol gallstone formation in experimental mice.
Reddy RL; Srinivasan K
Can J Physiol Pharmacol; 2009 Nov; 87(11):933-43. PubMed ID: 19935901
[TBL] [Abstract][Full Text] [Related]
20. Biliary cholesterol hypersecretion in gallstone-susceptible mice is associated with hepatic up-regulation of the high-density lipoprotein receptor SRBI.
Fuchs M; Ivandic B; Müller O; Schalla C; Scheibner J; Bartsch P; Stange EF
Hepatology; 2001 Jun; 33(6):1451-9. PubMed ID: 11391534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
